SCHEMBL22080331

SCHEMBL22080331

O=C(O)CCCCCCCCCCCCCc1ccc(Oc2ccc(S(=O)(=O)Nc3ncc(C(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)O)cn3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
PKM P14618 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 2/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
ALDH1A1 P00352 2/20 0.37
CA2 P00918 1/20 0.36
HDAC6 Q9UBN7 1/20 0.35
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
SGMS1 Q86VZ5 1/20 0.35
NR3C1 P04150 1/20 0.35
TBXA2R P21731 1/20 0.35
TBXAS1 P24557 1/20 0.35
FABP1 P07148 1/20 0.35
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24257979 0.98 MEN1 (0.37) TDP1SMN1; SMN2PKMMEN1KMT2A
SCHEMBL22079946 0.96 NPC1 (0.40) TDP1SMN1; SMN2PKMMEN1KMT2A
SCHEMBL22080333 0.96 NPC1 (0.40) TDP1SMN1; SMN2PKMMEN1KMT2A
SCHEMBL22029401 0.96 NPC1 (0.40) TDP1SMN1; SMN2PKMMEN1KMT2A
SCHEMBL24257988 0.96 NPC1 (0.40) TDP1SMN1; SMN2PKMMEN1KMT2A
SCHEMBL31682070 0.96 NPC1 (0.40) TDP1SMN1; SMN2PKMMEN1KMT2A
SCHEMBL24257961 0.95 SMN1; SMN2 (0.39) TDP1SMN1; SMN2PKMMEN1KMT2A
SCHEMBL22080442 0.95 SMN1; SMN2 (0.39) TDP1SMN1; SMN2PKMMEN1KMT2A
SCHEMBL24257857 0.94 TDP1 (0.44) TDP1SMN1; SMN2PKMMEN1KMT2A
SCHEMBL22079977 0.94 TDP1 (0.44) TDP1SMN1; SMN2PKMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3893934-B1 INSULIN CONJUGATES SANOFI SA (FR) 2025-09-10 EP disclosed
US-20220048968-A1 INSULIN CONJUGATES SANOFI (FR) 2022-02-17 US disclosed
US-20200181223-A1 INSULIN CONJUGATES SANOFI (FR) 2020-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200181223-A1 INSULIN CONJUGATES IAPP, INSR, IGF1R TDP1 4783/4885SMN1; SMN2 1332/4885PKM 1743/4885
US-20220048968-A1 INSULIN CONJUGATES IAPP, INSR, IGF1R TDP1 4783/4885SMN1; SMN2 1332/4885PKM 1743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.